Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma


Thomas Gruber | Steve Robatel | Mirela Kremenovic | Lukas Bäriswyl | Jürg Gertsch | Mirjam Schenk


In this study, using data from The Cancer Genome Atlas (TCGA)’s melanoma cohort, human melanoma tissues and murine models, as well as single-cell RNA sequencing, we uncover a critical role of CB2Rs in B cells in cutaneous melanoma. Cell 2000, 101, 455–458. ; et al. IL-32γ potentiates tumor immunity in melanoma. Cell. Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma Cancers 13, no.

Visit Link


Tags: